Filana Therapeutics, Inc. (FLNA)

Filana Therapeutics Statistics

Total Valuation

FLNA has a market cap or net worth of $67.39 million. The enterprise value is -$20.87 million.

Market Cap	67.39M
Enterprise Value	-20.87M

Important Dates

The last earnings date was Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

FLNA has 48.31 million shares outstanding.

Current Share Class	48.31M
Shares Outstanding	48.31M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.05%
Owned by Institutions (%)	28.42%
Float	47.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.96
P/TBV Ratio	0.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.19

Current Ratio	2.19
Quick Ratio	2.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -79.59% and return on invested capital (ROIC) is -31.72%.

Return on Equity (ROE)	-79.59%
Return on Assets (ROA)	-24.91%
Return on Invested Capital (ROIC)	-31.72%
Return on Capital Employed (ROCE)	-72.78%
Weighted Average Cost of Capital (WACC)	-0.01%
Revenue Per Employee	n/a
Profits Per Employee	-$3.90M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.49% in the last 52 weeks. The beta is -0.78, so FLNA's price volatility has been lower than the market average.

Beta (5Y)	-0.78
52-Week Price Change	-34.49%
50-Day Moving Average	1.51
200-Day Moving Average	2.35
Relative Strength Index (RSI)	49.04
Average Volume (20 Days)	385,024

Short Selling Information

The latest short interest is 6.69 million, so 13.85% of the outstanding shares have been sold short.

Short Interest	6.69M
Short Previous Month	6.85M
Short % of Shares Out	13.85%
Short % of Float	14.14%
Short Ratio (days to cover)	15.39

Income Statement

Revenue	n/a
Gross Profit	-17.47M
Operating Income	-49.67M
Pretax Income	-77.90M
Net Income	-77.90M
EBITDA	-48.71M
EBIT	-49.67M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has $86.57 million in cash and n/a in debt, with a net cash position of $86.57 million or $1.79 per share.

Cash & Cash Equivalents	86.57M
Total Debt	n/a
Net Cash	86.57M
Net Cash Per Share	$1.79
Equity (Book Value)	68.14M
Book Value Per Share	n/a
Working Capital	47.85M

Cash Flow

In the last 12 months, operating cash flow was -$29.79 million and capital expenditures -$581,000, giving a free cash flow of -$30.38 million.

Operating Cash Flow	-29.79M
Capital Expenditures	-581,000
Depreciation & Amortization	959,000
Net Borrowing	n/a
Free Cash Flow	-30.38M
FCF Per Share	-$0.63

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FLNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-118.57%
FCF Yield	-46.23%

Analyst Forecast

The average price target for FLNA is $6.50, which is 365.95% higher than the current price. The consensus rating is "Buy".

Price Target	$6.50
Price Target Difference	365.95%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 10, 2017. It was a reverse split with a ratio of 1:7.

Last Split Date	May 10, 2017
Split Type	Reverse
Split Ratio	1:7

Scores

Altman Z-Score	n/a
Piotroski F-Score	1